A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancers
Robert M. Brody(University of Pennsylvania), Devraj Basu(University of Pennsylvania), Phyllis A. Gimotty(University of Pennsylvania), Virginia A. LiVolsi(Hospital of the University of Pennsylvania), Steven B. Cannady(University of Pennsylvania), Umamaheswar Duvvuri(City University of New York), Christopher H. Rassekh(University of Pennsylvania), Charu Aggarwal(UPMC Hillman Cancer Center), Bert W. O’Malley(Baylor College of Medicine), Ryan M. Carey(Hospital of the University of Pennsylvania), Lee Hartner(Illinois CancerCare), Alexander Lin(University of Pennsylvania Health System), Rabie M. Shanti(University of Pennsylvania), Jason G. Newman(University of Pennsylvania), David Shimunov(University of Pennsylvania), Karthik Rajasekaran(University of Pennsylvania), Kathleen T. Montone, Gregory S. Weinstein(University of Pennsylvania), Roger B. Cohen(University of Pennsylvania), Jalal B. Jalaly(Penn Center for AIDS Research), Ara A. Chalian(University of Pennsylvania), John N. Lukens(Radiation Oncology Associates)
Cited by 16
Related Papers
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
|Science|2018|1.5k
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
|JAMA Oncology|2016|1.4k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k